COMPANY

Function Therapeutics

HQ: Milwaukee, WI source · functiontx.com ↗ · Midwest

Location: Milwaukee, WI · source · Oct 15, 2026

Profile checked Oct 10, 2026

7NIH grants

Funding and NIH signals

NIH award NIH awarded $200K (SBIR Phase I 5R43NS143450-02, continuation, notice Sep 18, 2026). NIH RePORTER 5R43NS143450-02 (Sep 18, 2026)
Evidence (1 event)
- Sep 18, 2026 · NIH RePORTER 5R43NS143450-02
  Organization: FUNCTION THERAPEUTICS, INC.; City/State: MILWAUKEE, WI; Project number: 5R43NS143450-02; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-18; FY total cost (award amount): 200070; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jan 6, 2026 Grant Government grant: $699,933 (up to, as announced), announced Jan 6, 2026. Source: company's own press page. source ↗

Funding

Last 2 years.

Jan 6, 2026 Government grant: $699,933 (up to, as announced), announced Jan 6, 2026. Source: company's own press page. source ↗

NIH awards 7

Annual award amounts. Total $1.9M.

Sep 18, 2026 NIH award 5R43NS143450-02 FY2026: $200,070 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Parmodulins without Abuse P source ↗
Sep 11, 2025 NIH award 5R43DK141373-02 FY2025: $39,740 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Small Molecule PAR1 Ligands source ↗
Sep 11, 2025 NIH award 1R43NS143450-01 FY2025: $499,863 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Parmodulins without Abuse P source ↗
Jul 2, 2025 NIH award 5R43DK138702-02 FY2025: $88,907 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Inhibitors of Thromboinflamm source ↗
Aug 7, 2024 NIH award 1R43DK141373-01 FY2024: $463,714 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Small Molecule PAR1 Ligands source ↗
May 10, 2024 NIH award 1R43DK138702-01A1 FY2024: $325,000 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Inhibitors of Thromboinfl source ↗
Aug 23, 2023 NIH award 1R43HL169107-01 FY2023: $299,790 awarded for that fiscal year; activity R43 (SBIR); PI DOCKENDORFF, CHRISTOPHER; recipient as written: FUNCTION THERAPEUTICS, INC., MILWAUKEE, WI. Allosteric Modulation of PA source ↗

Connect

See your connections at Function Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-04